NCT03338400View on ClinicalTrials.gov

Dexamethasone Administration To Improve Patient Recovery In Ambulatory Vaginal Prolapse Surgery: Is There A Role?

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

August 21, 2018

Study Completion Date

August 21, 2018

Conditions
Quality of RecoverySame Day SurgeryNausea and Vomiting, PostoperativeVaginal Prolapse
Interventions
DRUG

Dexamethasone

Patients will be randomized to Dexamethasone arm will receive 8mg (2ml) of Dexamethasone at the time of induction.

DRUG

Normal saline

Patients randomized to normal saline will receive 2ml of Normal saline at the time of induction.

Trial Locations (1)

33331

Cleveland Clinic Florida, Weston

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT03338400 - Dexamethasone Administration To Improve Patient Recovery In Ambulatory Vaginal Prolapse Surgery: Is There A Role? | Biotech Hunter | Biotech Hunter